CRISPR Therapeutics Vertex Pharmaceuticals: Better Buy in 2026
Investors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Which credit card has the best travel rewards program? This guide helps you compare top options to maximize your travel rewards.
28,014 articlesInvestors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
MercadoLibre posted a solid Q4 revenue beat alongside an earnings miss, underscoring margin pressure from growth init...
Investors turn to a resilient, income-focused mix to weather headlines and market swings in 2026. A practical framewo...
As tensions flare, Qatar’s plan to buy $4 billion in Patriot missiles reshapes security and markets. This article bre...
A sweeping government push to secure rare earths could reshape the landscape for USA Rare Earth. This guide breaks do...
As AI workloads surge, power reliability becomes a strategic bottleneck for data centers. This utility stock could of...
Bitcoin is moving independently of the Nasdaq as liquidity conditions tighten, a rare divergence that traders say cou...
A surge in corporate bond issuance is tightening the funding path for the U.S. government, with investors chasing rec...
The CFPB will publish an RFI in the Federal Register to solicit input on potential changes to TRID disclosures, resci...
A fintech founder chose financial discipline over prestige, turning down an invitation from President Obama to focus ...
Smart investing starts with the numbers. This article dissects SoFi Technologies through a valuation lens, delivering...
Bitcoin faces renewed pressure as a large overnight repo operation from the Federal Reserve coincides with stress in ...